Mereo BioPharma Group plc - Ordinary Shares (MREO)

CUSIP: 589492107

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 7 signals
Share change
-2,099,055
Put/Call ratio
145%
SEC-reported price per share
$2.42
Indexed holders
58
Value change
-$26,671,615
Number of buys
24
Open additional details 1 more signal available
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
833,333,333

Security key

589492107

Report period

Q3 2021

Indexed institutions

58

Top holders

10

Ownership snapshot

Top reported holders of MREO - Mereo BioPharma Group plc - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Point72 Asset Management,...
Disclosed value leader
Point72 Asset Management,...
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F Highest disclosed value: $32,040,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Point72 Asset Management, L.P. has the largest disclosed position value at $32.04M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Point72 Asset Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Point72 Asset Management, L.P. $32.04M
MONTANOVA CAPITAL, LLC $27.42M
Boxer Capital, LLC $19.74M
Rubric Capital Management LP $17.94M
Rock Springs Capital Management LP $14.4M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$32,040,000
10,107,189 shares
— 30 Jun 2021
MONTANOVA CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$27,418,000
8,649,300 shares
— 30 Jun 2021
Boxer Capital, LLC
13F
Company
13F
—
denominator unverified
$19,739,000
6,226,673 shares
— 30 Jun 2021
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$17,944,000
5,660,608 shares
— 30 Jun 2021
Rock Springs Capital Management LP
13F
Company
13F
—
denominator unverified
$14,401,000
4,542,769 shares
— 30 Jun 2021
Vivo Capital, LLC
13F
Company
13F
—
denominator unverified
$13,380,000
4,220,938 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
58
Shares
87,544,301
Indexed holders
58
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 indexed holders
68
Q3 2021 indexed holders
58
Indexed holder difference
-10
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .